Internal Medicine, Infectious Disease · Voorhees, NJ
NPI
1942407374
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
709 Haddonfield Berlin Rd
Voorhees, NJ, 08043
Phone (856) 566-3190
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
921 services
Medicare patients, 2024
469
Average age 73
Drug cost, 2024
$1.9M
2,049 prescriptions
Company payments, 2025
$38.96
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark J Fussa was code 99233 (hospital e&m - subsequent), 334 times for 196 patients. In total Mark J Fussa billed 921 services in 20 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 334 | 196 | $96.14 | $32K |
| 99232 Hospital E&M - Subsequent | Facility | 158 | 126 | $64.37 | $10K |
| 99222 Hospital E&M - Initial | Facility | 151 | 149 | $103.94 | $16K |
| 99223 Hospital E&M - Initial | Facility | 68 | 67 | $137.38 | $9,342 |
| 99214 Office E&M - Established | Office | 59 | 40 | $62.90 | $3,711 |
| 99213 Office E&M - Established | Office | 57 | 44 | $51.18 | $2,917 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 26 | 20 | $13.03 | $339 |
| 99451 E&M - Miscellaneous | Facility | 16 | 14 | $28.77 | $460 |
By year: 2022 $76K for 996 services; 2023 $85K for 945 services; 2024 $77K for 921 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark J Fussa prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 121 prescriptions and refills. In total Mark J Fussa wrote 2,049 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 121 | 128 | 13 | $512K |
| Valacyclovir Valacyclovir Hcl | 77 | 93 | 11 | $3,070 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 70 | 70 | Under 11 | $287K |
| Descovy Emtricitabine/Tenofov Alafenam | 68 | 76 | Under 11 | $153K |
| Atorvastatin Calcium Generic | 66 | 117 | 11 | $277 |
| Amlodipine Besylate Generic | 54 | 58 | Under 11 | $74.85 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 54 | 55 | Under 11 | $1,430 |
| Omeprazole Generic | 52 | 52 | Under 11 | $75.8 |
| Lisinopril Generic | 50 | 67 | Under 11 | $82.18 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 48 | 48 | Under 11 | $169K |
| Tivicay Dolutegravir Sodium | 47 | 47 | Under 11 | $96K |
| Rosuvastatin Calcium Generic | 42 | 66 | Under 11 | $363 |
| Levocetirizine Dihydrochloride Generic | 40 | 60 | Under 11 | $166 |
| Juluca Dolutegravir/Rilpivirine | 37 | 37 | Under 11 | $124K |
| Zolpidem Tartrate Generic | 35 | 35 | Under 11 | $180 |
Brand drugs: - claims; generic drugs: 1,416 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark J Fussa $38.96 ($38.96 in general payments such as food, travel and fees) from 2 companies. The largest payer was ViiV Healthcare Company with $19.92.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.